Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Processes for generating TIL products enriched for tumor antigen-specific t-cells

Processes for generating TIL products enriched for tumor antigen-specific t-cells

US Patent 12104172 · Granted Oct 1, 2024

Estimated economic value: $63,374,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2025
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2025
Expansion of TILs utilizing AKT pathways inhibitors2025
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2024
Processes for generating TIL products enriched for tumor antigen-specific T-cell2023
Processes for generating TIL products enriched for tumor antigen-specific T-cell2023
Closed process for expansion and gene editing of tumor infiltrating lymphocytes 2022